Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Acquisition Strategy Sets Medical Transcription Billing Corp. (MTBC) on Pace for Incremental Profits

Recently posting its fourth straight quarter of positive adjusted EBITDA and another quarter of YoY revenue growth, healthcare IT company Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP) is demonstrating increased momentum of its aggressive acquisition-based strategy. The company most recently acquired Texas-based medical billing company MediGain, LLC, including substantially all of its assets and its subsidiary, for $7 million. “In total, the accounts in good standing acquired through this transaction have annual revenues in excess of $10 million … the MediGain acquisition is expected to be accretive to MTBC shareholders in 2017, as incremental profits are expected to greatly exceed cost of capital. The acquisition also expanded MTBC’s global workforce, adding experienced team members in North America, as well as talented, cost-effective workforces in Asia.”

To view the full article, visit:

About MTBC

Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based and mobile health solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.” For more information on MTBC, please visit

This entry was posted in Medical Transcription Billing, Corp. MTBC. Bookmark the permalink.

Comments are closed.